Cargando…
Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma
Primary effusion lymphoma (PEL) is caused by Kaposi’s sarcoma-associated herpesvirus. Our understanding of PEL is poor and therefore treatment strategies are lacking. To address this need, we conducted genome-wide CRISPR/Cas9 knockout screens in eight PEL cell lines. Integration with data from unrel...
Autores principales: | Manzano, Mark, Patil, Ajinkya, Waldrop, Alexander, Dave, Sandeep S., Behdad, Amir, Gottwein, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093911/ https://www.ncbi.nlm.nih.gov/pubmed/30111820 http://dx.doi.org/10.1038/s41467-018-05506-9 |
Ejemplares similares
-
Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma
por: Lan, Jungang, et al.
Publicado: (2023) -
Kaposi’s Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma
por: Manzano, Mark, et al.
Publicado: (2020) -
Herpesviral Latency—Common Themes
por: Weidner-Glunde, Magdalena, et al.
Publicado: (2020) -
A Two-tiered functional screen identifies herpesviral transcriptional modifiers and their essential domains
por: Morgens, David W., et al.
Publicado: (2022) -
Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors
por: Wang, Chong, et al.
Publicado: (2020)